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Abstract: New bifunctional quinone methide (QM) precursors, bisphenols 2a–2e, and monofunctional QM precursor 7 were synthesized. Upon 
treatment with fluoride, desilylation triggers formation of reactive intermediates, QMs, which was demonstrated by trapping QM with azide or 
methanol. The ability of QMs to alkylate and cross-link DNA was assayed by investigation of the effects of QMs to DNA denaturing, but without 
conclusive evidence. Furthermore, treatment of a plasmid DNA with compounds 2a–2e and KF, followed by the analysis by alkaline denaturing 
gel electrophoresis, did not provide evidence for the DNA cross-linking. MTT test performed on two human cancer cell lines (MCF7 breast 
adenocarcinoma and SUM159 pleomorphic breast carcinoma), with and without fluoride, indicated that 2a–2e or the corresponding QMs did 
not exhibit cytotoxic activity, in line with the lack of ability to cross-link DNA. The lack of reactivity with DNA and biological activity were 
explained by sequential formation of QMs where bifunctional cytotoxic reagent is probably never produced. Instead, the sequential generation 
of monofunctional QM followed by a faster hydrolysis leads to the destruction of biologically active reagent. The findings described here are 
particularly important for the rational design of new generation of QM precursor molecules that will attain desirable DNA reactivity and 
cytotoxicity. 
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INTRODUCTION 
UINONE methides (QMs) are important inter-
mediates in chemistry and photochemistry of 
phenols,[1] owing to their applications in organic syn-
thesis,[2] and biological activity.[3] It has been demonstrated 
that QMs react with amino acids[4] and proteins,[5] and 
inhibition of some enzymes has been reported including 
hydroxylases,[6] β-lactamase,[7] β-glucosidases,[8] phosphat-
ase[9] or ribonuclease-A.[10] However, biological action of 
QMs has mostly been related to their reactivity with 
nucleosides[11] and alkylation of DNA,[12] since some 
anticancer antibiotics such as mitomycin[13] exert their 
antiproliferative action on metabolic formation of QMs that 
alkylate DNA. In particular, S. Rokita et al. demonstrated 
reversible alkylation ability of QMs leading to 
"immortalization of QM" by DNA as a nucleophile,[14] 
whereas Freccero et al. investigated ability of QMs to 
alkylate G4 regions of DNA.[15] 
 QMs are very reactive species that cannot be stored, 
they have to be generated in situ. Some thermal reactions 
to generate QMs include oxidation of phenols,[16] 
dehydration from hydroxybenzyl alcohols,[17] elimination of 
nitriles from 1,2-benzoxazines,[18] and the most extensively 
used, fluoride induced desilylation.[12b,c] On the other hand, 
photochemical methods offer much milder approach to 
QMs, particularly for biological systems.[19] The most 
common reactions to generate QMs in photochemical 
reactions are photodehydration[20] and photodeamination 
from the suitably substituted phenols.[4,21] An on-going 
interest in our group is the photochemical generation of 
quinone methides (QM) from suitable precursors, and 
investigation of their biological effects.[22] In particular, we 
have recently demonstrated that photogenerated QM 
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formed from anthrol 1 (Scheme 1) exhibit higher 
cytotoxicity on cancer stem cell lines then on normal cancer 
cells.[23] Interestingly, our results indicate that enhanced 
antiproliferative effects probably does not originate from 
the reaction of QMs with DNA, but rather with proteins, 
since we have shown that compounds do not enter cell 
nucleus.[22d,23] However, all molecules that we studied to 
date were monofunctional, so in principle, they could only 
alkylate DNA. On the other hand, DNA cross-linking by bi-
functional molecules is known to be the most cytotoxic 
event leading to the cell death.[24] 
 Herein we report an investigation of F− induced 
desilylation and generation of bi-functional QMs that are 
anticipated to enable DNA cross-linking (Figure 1). 
Bisphenol derivatives 2 are bi-functional derivatives of 
phenols that are substituted by TBDMS at the phenolic 
oxygen and by acetyl at the benzyl alcohol. According to 
literature precedent, F− induced desilylation should induce 
the cleavage of the silyl group, elimination of the acetyl and 
formation of QMs.[12b,c] The QM precursors are separated 
by alkyl spacer of different lengths to probe for the effect 
of molecular structure to the efficiency of DNA cross-
linking. 
 Formation of QMs was probed by F− induced 
reactions and trapping with nucleophiles. Antiproliferative 
activity of bisphenols was investigated in vitro against two 
human cancer cell lines: MCF-7 (breast adenocarcinoma) 
and SUM159 (pleomorphic breast carcinoma). The idea was 
to link the antiproliferative activity to the ability of QMs to 
cross-link DNA molecules. Interestingly, treatment of 
plasmid DNA in the presence of bisphenols and analysis by 
alkaline agarose electrophoresis, or measurement of DNA 
denaturation show that QMs do not cross-link plasmid 
DNA, and the reasons for the lack of reactivity were 
disclosed. 
 
RESULTS 
Synthesis 
Synthesis of bis-QM precursors was based on the one-pot 
double Grignard reaction with the appropriately protected 
OH
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Scheme 1. Photochemical dehydration on anthrol 1 and formation of QM1 that exhibits cytotoxicity on cancer stem cells. 
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Figure 1. Structures of bifunctional QM precursors. 
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Scheme 2. Synthesis of bisphenol QM precursors. 
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carbaldehyde. Salicylaldehyde component was TBDMS-
protected 3[25] (for the preparation see the SI) that reacted 
with double Grignard reagent formed from 1,n-dibromo-
alkane. The reaction gave alkoxide intermediates that can 
be quenched by H2O and isolated as alcohols 4, or 
acetylated in one-pot (Scheme 2). An attempt to quench 
the alkoxide with acetic anhydride failed, but the treatment 
with acetyl chloride was successful giving acetyl esters. The 
one pot procedure gave better yields and one purification 
step less was needed. It should be noted that the double 
Grignard reaction created two stereogenic centers in 4 or 
2, and therefore, a mixture of two enantiomers (RR, SS) and 
the meso-compound (SR) were obtained, which were 
inseparable by achiral chromatography. 
 On attempts to prepare bisphenol containing alkyl 
spacer with less than 6 C-atoms, in the Grignard reaction 
with 1,4-dibromobutane or 1,3-dibromopropane, a reduc-
tion of the TBDMS-protected aldehyde took place giving 
benzyl alcohol 5. Such β-hydride transfer reactions are 
known to compete with Grignard reactions,[26] particularly 
with sterically congested carbonyl groups.[27] In our case, 
the di-Grignard reagent formed from 1,4-dibromobutane 
contained reactive H-atoms at the β-position (Figure 2), 
allowing the facile β-hydride transfer and preventing the 
addition to the carbonyl group. Furthermore, based on 
literature precedent, formation of di-Grignard reagent 
from 1,3-dibromopropane is proble-matic since the di-
Grignard reagent is very unstable.[28] Therefore, only bis-
phenols containing more than 6 C atoms in the linker were 
synthesized. In addition to bisphenol derivatives, we have 
synthesized also model compounds 6 and 7 (Figure 3), that 
contain only one phenol moiety, and which were needed in 
the biological investigations. 
QM Formation by F− Induced Desilylation 
Formation of QM in the desilylation reaction was first probed 
on model compound 7. The compound was dissolved in 
DMSO and diluted with PBS buffer (pH 7.4). Formation of QM 
was initiated by addition of KF (incubation 1 h). The 
formation of QMs was proven by quenching with nucleo-
philes, NaN3, the ubiquitous QM quencher[19] whereupon 
adduct 8 was isolated by preparative HPLC (Scheme 3). 
Furthermore, we have shown that adducts were formed 
practically immediately after the addition of KF, whereas in 
the absence of KF adducts were not formed over 24 h. 
 To show that bisphenols can also undergo F− 
desilylation giving QMs we have treated 2c with KF in 
methanolic solution. The reaction gave two products 9 and 
10 (Scheme 4) that were isolated and characterized. 
Formation of 10, where only one benzyl alcohol is sub-
stituted by methoxy group indicates that formation of QMs 
and methanolysis probably take place sequentially. That is, 
upon formation of a QM, the reaction of solvolysis probably 
takes place more rapidly than formation of the second QM 
in the same molecule. Thus, it is not probable that one 
molecule contains two QM centers at the same time. 
Investigation of DNA Cross-linking 
Ability of Compounds 
After demonstrating that F− induces formation of QMs, 
DNA cross-linking ability of bisphenols 2 was assayed. 
Plasmid pCMVbeta DNA (2 μg) in PBS buffer was mixed with 
2a–2e and 7 (1 mM), and treated with KF (200 mM). After 
18 h incubation, the alkaline agarose gel electrophoresis 
was performed, as described in the Experimental section. 
As a positive control, plasmid was irradiated in the 
presence of psoralene derivative that is known to cross-link 
DNA.[12d] Interstrand cross-linking activities of psoralen 
were evident as X-band of circular form (X-CC). However, 
no X-bands and no difference in migratory ability compared 
to control DNA were observed in the presence of 2 (Figure 4). 
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Figure 2. Structure of C-4 di-Grignard reagent that is prone 
to β-hydride transfer. 
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Figure 3. Structure of products 5–7. 
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Scheme 3. F− induced formation of QM and reaction with NaN3. 
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Investigation of the DNA Cross-linking 
by Thermal Denaturation 
Compounds that bind to DNA cause stabilization of the 
duplex and increase of the DNA melting temperature (∆Tm). 
Similarly, we anticipated that the covalent binding, and 
particularly, cross-linking of DNA should affect the ∆Tm. 
Therefore, the ability of compounds 2b–2e to form bifun-
ctional QMs and cross-link DNA was assayed also by their 
effects on ∆Tm (Figure 5 and Figures S1 and S2 in the sup-
porting information). The problem in the measurement 
represented poor solubility of 2 under these conditions. 
Therefore, the measurement was conducted in H2O-DMSO 
solvent mixture (9:1, or 8:2 for 2c), containing sodium 
cacodylate buffer (c = 0.05 M, pH = 7.0). Under such con-
ditions, ct-DNA revealed Tm = 75.1±0.5 °C. Addition of 
compounds alone or in combination with KF did not affect 
the Tm significantly, changes being within the error of the 
method (±0.5 °C, Figure 5), suggesting that the eventual 
alkylation and cross-linking was either of very low efficiency 
(leaving large amount of free DNA available for denatur-
ation) or did not take place at all. However, the thermal 
denaturation experiment could not give the unambiguous 
conclusion whether QMs from 2 were able to alkylate and 
cross-link at least some of DNA, since even low cross-linking 
efficiency could have measurable biological effect. Therefore, 
we decided to assay these systems on human cancer cell lines. 
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Scheme 4. F− induced methanolysis from bisphenol 2c. 
 
 
 
Figure 4. Alkaline agarose gel electrophoresis: pCMVbeta plasmid DNA (2 μg) in PBS buffer (pH = 7.4) was mixed with 2a–2e or 
7 (1 mM), and KF (200 mM). After 18 h incubation, the samples were loaded and the gel was running for 5 h. Columns from left 
to right: 1) plasmid DNA, 2) psoralen (PS) (20 μM) and irradiation 5 min at 300 nm, 3) 2a 4) 2b, 5) 2c, 6) 2d, 7) 2e, 8) 7. CC-closed 
circular DNA, OC-open circular DNA, L-linear DNA, X- cross-linked DNA. 
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Antiproliferative Activity 
Antiproliferative effect of the F− generated QMs on two 
cancer cell lines, MCF7 (breast adenocarcinoma) and 
SUM159 (pleomorphic breast carcinoma) was investigated. 
Cells were divided into two groups; cells treated with 
compounds and KF, and cells that were treated only with 
compounds. KF was added two hours after the compounds 
in order to allow bisphenols to permeate the cell’s 
membrane. Cells were incubated with all of the compounds 
for three days. The activities expressed as IC50 (concen-
tration that causes 50 % inhibition of the cell growth) are 
compiled in Table 1. In general, all of the compounds 
exhibited low antiproliferative activity. Compound 7 had 
moderate activity toward MCF7 cells. We observed 
enhancement of cytotoxicity in SUM159 cells upon 
activation of compound 7 with KF, but this effect could also 
be attributed to toxicity of KF toward SUM159 cell line 
(Figure S4). Small improvement of cytotoxicity was also 
observed in MCF7 cells after activation of compound 2d. 
 
DISCUSSION 
The treatment of monofunctional QM precursor 7 with KF 
in the presence of azide whereupon adduct 8 was isolated 
clearly indicated that F− induced formation of QMs, in 
accord with literature precedent.[12b,c] Furthermore, KF 
induced methanolysis of bisphenol 2c, indicating that 
formation of QMs takes place upon treatment of 2a-2e with 
KF. However, we do not have any evidence if the formation 
of bis-QM takes place (such as 2a-bisQM, Scheme 5). 
Namely, it is plausible that F− induced formation of QM 
takes place stepwise giving 2a-QM. In principle, this 
monofunctional QM molecule can undergo two competitive 
reactions, hydrolysis to 11 and secondary elimination to  
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Figure 5. Normalized dependence of the ct-DNA (1.76 × 10−5 M) absorbance at 260 nm, in H2O-DMSO (8:2) containing sodium 
cacodylate buffer (c = 0.05 M, pH = 7.0), neat or in the presence of 2c (1.6 × 10−3 M), or 2c (1.6 × 10−3 M) and KF (0.2 M) after 
incubation for 3 h. 
 
Table 1. IC50 values (in µM)(a) induced with compounds 2 and 7 
 SUM159 MCF7 
Comp. No F− F− (1 mM) No F− F− (1 mM) 
2a >100 >100 >100 >100 
2b >100 >100 >100 >100 
2c >100 >100 >100 >100 
2d >100 >100 >100 77 ± 27 
2e >100 >100 >100 >100 
7 >100 63.5 ± 0.6 28 ± 4 24 ± 2 
(a) Concentration that causes 50 % inhibition of tumor cell growth. 
T / °C 
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2a-bisQM. The concentration of 2a-bisQM is therefore 
determined by a ratio of the corresponding reaction rate 
constants and concentrations [F−] vs [H2O]. Hydrolyzed 
product 11 can also undergo F− induced elimination giving 11-
QM. Eventually, both reactive sides in 2a are used and 
transformed to the bis-hydroxymethylphenol 12, which is 
not reactive. 
 Pathways presented in Scheme 5 may account for 
the lack of DNA cross-linking with compounds 2. Namely, 
the cross-linking is only feasible if 2a-bisQM is formed, or if 
2a-QM reacts faster with DNA then with H2O. Although, the 
hydrolyzed product 11 forms 11-QM, it can only alkylate 
DNA and cannot induce DNA cross-linking. This situation is 
different to bifunctional phenols bearing leaving groups at 
the position 2 and 6, such as 13. We have demonstrated by 
transient spectroscopy that 13 undergoes photodeamin-
ation giving 13-QMa. The attack of a nucleophile to 13-
QMa at the methylene 2 position gives new QM with a 
methylene at the 6 position, 13-QMb (Figure 6).[21b] This 
specific reactivity of bifunctional QMs leads to long-lived 
transient species and enable reversible reactions of the QM 
along a DNA chain as if the QM "walks on the DNA".[29] 
 Attempts to induce DNA cross-linking by 2a–2e and 7, 
and probe the process by the alkaline agarose gel 
electrophoresis or thermal denaturation failed, or gave no 
unambiguous conclusion. Furthermore, we have shown that 
compounds in the presence of KF do not exhibit cytotoxicity. 
These findings indicate that bisphenols 2 probably do not 
form bifunctional QMs. Consequently, they cannot cross-link 
DNA and do not show significant cytotoxicity. 
 
CONCLUSION 
Monofunctional and bifunctional quinone methide (QM) 
precursors were synthesized and their ability to form QMs 
in the reaction with fluoride was demonstrated. The ability 
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Scheme 5. Plausible pathways for the formation of QM and bisQM from 2a and their hydrolysis. 
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of QMs to alkylate and cross-link DNA was assayed by 
investigation of the effects of QMs to DNA denaturing and 
the treatment of a plasmid DNA with compounds 2a–2e 
and 7, and KF, followed by the analysis by alkaline 
denaturing gel electrophoresis. Both methods did not 
provide evidence for the DNA cross-linking, in agreement 
with the MTT test performed on two human cancer cell 
lines (MCF7 breast adenocarcinoma and SUM159 pleo-
morphic breast carcinoma), which indicated that 2a–2e or 
the corresponding QMs did not exhibit significant cytotoxic 
activity. The lack of DNA reactivity was rationalized by 
sequential formation of QMs where bifunctional cytotoxic 
reagent is probably never produced. Instead, the seq-
uential generation of monofunctional QM followed by a 
faster hydrolysis leads to the destruction of biologically 
active reagent. The findings described here are particularly 
important for the rational design of new generation of QM 
precursor molecules that should have structures that enable 
long-lived QM species such as 2,6-bifunctional phenols. 
 
EXPERIMENTAL 
General 
Chemicals for the synthesis were purchased from the 
usual suppliers, whereas solvents for the synthesis and 
chromatographic separations were purified by distil-
lation, or used as received (p.a. grade). 1H and 13C NMR 
spectra were recorded on a Bruker AV- 300, 400 or 600 
MHz. The NMR spectra were taken in CDCl3 or DMSO-d6 
at rt using TMS as a reference. HRMS were obtained on an 
Applied Biosystems 4800 Plus MALDI TOF/TOF instrument 
(AB, Foster City, CA). For the sample analysis a Shimadzu 
HPLC equipped with a Diode-Array detector and a 
Phenomenex Luna 3u C18(2) column was used. Mobile 
phase was CH3OH-H2O (20 %). For the chromatographic 
separations silica gel (Merck 0.05-0.2mm) was used. 
Analytical thin layer chromatography was performed on 
Polygram® SILG/UV254 (Machery-Nagel) plates. In the 
irradiation experiments, CH3CN and MeOH were HPLC 
grade pure, and mQ-H2O (Millipore) was used. ct-DNA was 
purchased from Aldrich. Preparation of known precursor 
molecule 5 is fully described in the ESI. 
1-[2-(tert-Butyldimethylsilyloxy)phenyl]propane-1-ol (6) 
In a two neck flask (25 mL), equipped with a condenser and 
septum, under inert N2 atmosphere, Mg (0.12 g, 4.94 
mmol), dry THF (2 mL) and a crystal of iodine were added. 
A small quantity of the solution of bromoethane (0.36 mL, 
4.83 mmol) in THF (5 mL) was added dropwise through the 
septum via a syringe. When the reaction was initiated by 
heating, the remaining bromoethane solution was added at 
rt. After the addition was complete, the reaction mixture 
was heated at the temperature of reflux 1 h, cooled to rt, 
and a solution of the protected salicylaldehyde (3, 0.95 g, 
4.01 mmol) in THF (5 mL) was added dropwise. The reaction 
mixture was stirred at rt 2 h, and then a saturated aqueous 
solution of NH4Cl (5 mL) was added, and the mixture was 
stirred 15 min. The mixture was transferred to a separatory 
funnel, the layers were separated and the aqueous layer 
was extracted with ethyl acetate (3×15 mL). The organic 
extracts were dried over anhydrous MgSO4, filtered, and 
the solvent was removed on a rotary evaporator. The re-
sidue was chromatographed on a column of silica gel using 
hexane/ethyl acetate (7:3) as eluent to afford the pure 
product (0.89 g, 84 %) in the form of colorless viscous oil.  
 1H NMR (CDCl3, 300 MHz) δ/ppm: 7.36 (dd, 1H, J = 
7.6 Hz, J = 1.7 Hz), 7.13 (td, 1H, J = 7.7 Hz, J = 1.9 Hz), 6.95 
(td, 1H, J = 7.4 Hz, J = 0.8 Hz), 6.79 (dd, 1H, J = 8.1 Hz, J = 0.9 
Hz), 4.95-4.85 (m, 1H), 2.12 (d, 1H, J = 4.5 Hz), 1.84-1.68 (m, 
2H), 1.02 (s, 9H), 0.3 (s, 6H). 13C NMR (CDCl3, 100 MHz) 
δ/ppm: 152.5, 134.8, 127.8, 126.8, 121.1, 118.1, 71.0, 30.4, 
25.8, 18.2, 10.3, −4.02, −4.1. 
 
1-[2-(tert-Butyldimethylsilyloxy)phenyl]prop-1-yl-acetate 
(7) 
A two neck flask (5 mL), equipped with a condenser and 
septum, under N2 inert atmosphere, was charged with 6 
(0.14 g, 0.52 mmol), ether (2 mL) and pyridine (0.10 mL, 
1.24 mmol). The reaction mixture was heated at reflux for 
5 min and then cooled to rt. Acetyl chloride (0.09 mL, 1.27 
mmol) was added and the mixture was heated at reflux for 
3 h. The solvent was removed on a rotary evaporator and the 
residue was chromatographed on a column of silica gel using 
hexane/diethyl ether (9:1) as eluent to afford the pure pro-
duct (0.055 g, 35 %) in the form of colorless viscous oil. 
O
CH3
CH2Me2HN
O
CH3
H2C Nu
OH
CH3
Me2HN NHMe2
13 13-QMa 13-QMb  
Figure 6. Structure of bifunctional QM precursor 13 and the corresponding QMs. 
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 1H NMR (CDCl3, 600 MHz) δ/ppm: 7.28 (dd, 1H, J = 7.6 
Hz, J = 1.6 Hz), 7.13 (td, 1H, J = 8.0 Hz, J = 1.5 Hz), 6.93 (td, 1H, 
J = 7.5 Hz, J = 0.8 Hz), 6.79 (dd, 1H, J = 8.1 Hz, J = 0.9 Hz), 6.09 
(t, 1H, J = 6.4 Hz), 2.08 (s, 3H), 1.84–1.77 (m, 2H), 1.03 (s, 9H), 
0.89 (t, 3H, J = 7.4 Hz), 0.27 (s, 6H); 13C NMR (CDCl3, 150 MHz) 
δ/ppm: 170.1, 152.4, 131.6, 128.1, 126.6, 120.9, 118.2, 71.9, 
28.5, 25.7, 21.1, 19.4, 9.7, −4.1. HRMS (MALDI TOF/TOF): 
calcd. for C17H28O3Si [M+H]+ 309.1886; found 309.1880. 
One-pot Synthesis of 7 
In a two neck flask (25 mL), equipped with a condenser and 
septum, under inert N2 atmosphere, Mg (0.060 g, 2.47 
mmol), dry THF (2mL) and a crystal of iodine were added. A 
small quantity of the solution of bromoethane (0.18 mL, 
2.41 mmol) in THF (5 mL) was added dropwise through the 
septum via a syringe. When the reaction was initiated by 
heating, the remaining bromoethane solution was added at 
rt. After the addition was complete, the reaction mixture 
was heated at the temperature of reflux for 1 h, cooled to 
rt, and a solution of the protected salicylaldehyde (3, 0.47 
g, 2.00 mmol,) in THF (3 mL) was added dropwise. The 
reaction mixture was stirred at rt for 1 h, and then acetyl 
chloride (0.18 mL, 2.53 mmol) was added and the stirring 
was continued over 2 h. The solvent was removed on a 
rotary evaporator and the residue was purified on a column 
of silica gel using hexane/diethyl ether (9:1) as eluent to 
afford the pure product (0.36 g, 58 %) in the form of 
colorless viscous oil. 
 
Preparation of Bisphenol Derivatives 4 - General 
Procedure 
In a two neck flask (50 mL), equipped with a condenser and 
septum, under inert N2 atmosphere, Mg (1.5 mmol), dry 
diethyl ether (1 mL / 1 mmol Mg) and a crystal of iodine 
were added. A small quantity of the solution of 1,n-
dibromoalkane (0.6 mmol) in ether (5 mL / 1 mmol) was 
added dropwise through the septum via a syringe. When 
the reaction was initiated by heating, the remaining 
dibromoalkane solution was added at rt or with a moderate 
heating. After the addition was complete, the reaction 
mixture was heated at the temperature of reflux for 1 h, 
cooled to rt, and a solution of the protected salicylaldehyde 
(3, 1 mmol) in dry ether (2.5 mL) was added dropwise. The 
reaction mixture was stirred at rt for 2 h, and then a 
saturated aqueous solution of NH4Cl (5 mL) was added and 
the mixture was stirred for 15 min. The mixture was 
transferred to a separatory funnel, the layers were separa-
ted and the aqueous layer was extracted with ethyl acetate 
(3×15 mL). The organic extracts were dried over anhydrous 
MgSO4, fil-tered, and the solvent was removed on a rotary 
evaporator. The residue was chromatographed on a co-
lumn of silica gel using hexane/ethyl acetate (7:3) as eluent. 
 
1,6-Bis[2-(tert-butyldimethylsilyloxy)phenyl]hexane-1,6-
diol (4a) 
According to the general procedure, the Grignard reagent 
was prepared from 1,4-dibromobutane (0.395 mL, 3.30 
mmol) and Mg (0.218 g, 8.97 mmol) in dry ether. In the 
reaction with the protected aldehyde (5, 1.30 g, 5.52 mmol) 
the product (0.26 g, 48 %) was obtained in the form of 
colorless viscous oil. 
 1H NMR (CDCl3, 300 MHz) δ/ppm: 7.33 (dd, 2H, J = 
7.6 Hz, J = 1.4 Hz), 7.12 (td, 2H, J = 8.0 Hz, J = 1.7 Hz), 6.95 
(td, 2H, J = 7.5 Hz, J = 0.8 Hz), 6.78 (dd, 2H, J = 8.0 Hz, J = 0.7 
Hz), 4.99-4.89 (m, 2H), 2.15 (br s, 2H), 1.80-1.69 (m, 4H), 
1.45-1.31 (m, 4H), 1.00 (s, 18H), 0.26 (s, 12H); 13C NMR 
(CDCl3, 75 MHz) δ / ppm: 152.4, 134.9, 127.9, 126.79, 
126.78, 121.2, 118.1, 69.86, 69.81, 37.5, 37.4, 26.2, 26.1, 
25.8, 18.2, −4.1; HRMS (MALDI TOF/TOF): calcd for 
C30H50O4Si2 [M+Na]+ 553.3145; found 553.3140. 
 
1,7-Bis[2-(tert-butyldimethylsilyloxy)phenyl]heptane-1,7-
diol (4b) 
According to the general procedure, the Grignard reagent 
was prepared from 1,5-dibromopentane (0.45 mL, 3.33 mmol) 
and Mg (0.22 g, 8.97 mmol) in dry ether. In the reaction with 
the protected aldehyde (5, 1.30 g, 5.52 mmol) the product 
(0.26 g, 48 %) was obtained in the form of colorless viscous oil. 
 1H NMR (CDCl3, 300 MHz) δ/ppm: 7.34 (dd, 2H, J = 
7.5 Hz, J = 1.5 Hz), 7.11 (td, 2H, J = 7.8 Hz, J = 1.7 Hz), 6.94 
(dd (t), 2H, J = 7.5 Hz), 6.78 (d, 2H, J = 7.8 Hz), 4.98–4.90 (m, 
2H), 2.13-2.11 (m, 2H), 1.76–1.69 (m, 4H), 1.53–1.48 (m, 
2H), 1.39–1.29 (m, 4H), 1.01 (s, 18H), 0.26 (s, 12H); 13C NMR 
(CDCl3, 150 MHz) δ / ppm: 152.4, 134.9, 127.8, 126.7, 121.1, 
118.1, 69.7, 37.4, 29.7, 26.0, 25.7, 18.1, −4.1; HRMS (MALDI 
TOF/TOF): calcd. for C31H55O4Si2 [M+Na]+ 567.3302; found 
567.3309. 
 
1,8-Bis[2-(tert-butyldimethylsilyloxy)phenyl]octane-1,8-
diol (4c) 
According to the general procedure, the Grignard reagent 
was prepared from 1,6-dibromohexane (0.52 mL, 2.74 
mmol) and Mg (0.22 g, 8.97 mmol) in dry ether. In the 
reaction with the protected aldehyde (5, 1.30 g, 5.52 mmol) 
the product (0.26 g, 48 %) was obtained in the form of 
colorless viscous oil. 
 1H NMR (CDCl3, 300 MHz) δ/ppm: 7.34 (dd, 2H, J = 
7.5 Hz, J = 1.6 Hz), 7.12 (td, 2H, J = 8.0 Hz, J = 1.8 Hz), 6.95 
(td, 2H, J = 7.5 Hz, J = 0.8 Hz), 6.78 (dd, 2H, J = 8.0 Hz, J = 0.8 
Hz), 4.98–4.90 (m, 2H), 2.11 (d, 2H, J = 4.8 Hz), 1.76-1.69 
(m, 4H), 1.57–1.47 (m, 2H), 1.36–1.26 (m, 6H), 1.01 (s, 18H), 
0.26 (s, 12H); 13C NMR (CDCl3, 150 MHz) δ/ppm: 152.4, 
135.0, 127.8, 126.7, 121.1, 118.1, 69.7, 37.5, 29.6, 25.9, 
25.7, 18.2, −4.1; HRMS (MALDI TOF/TOF): calcd for 
C32H54O4Si2 [M+Na]+ 581.3458; found 581.3469. 
 
 
 
 
 M. SAMBOL et al.: Bifunctional Phenol Quinone Methide Precursors 37 
 
DOI: 10.5562/cca3455 Croat. Chem. Acta 2019, 92(1), 29–41 
 
 
 
Acetylation of 4 - General Procedure 
A two neck flask (20 mL), equipped with a condenser and 
septum, under N2 inert atmosphere, was charged with 4 (1 
mmol), ether (10 mL) and pyridine (4.4 mmol). The reaction 
mixture was heated at reflux for 5 min and then cooled to 
rt. Acetyl chloride (4.5 mmol) was added and the mixture 
was heated at reflux for 30 min. The solvent was removed 
on a rotary evaporator and the residue was chroma-
tographed on a column of silica gel using hexane/diethyl 
ether (9:1) as eluent to afford the pure product. 
 
1,6-Bis[2-(tert-butyldimethylsilyloxy)phenyl]hexane-1,6-
diacetate (2a) 
According to the general procedure, from 4a (0.27 g, 0.50 
mmol), acetyl chloride (0.16 g, 2.25 mmol) and pyridine the 
reaction furnished the product (0.27 g, 87 %) in the form of 
colorless viscous oil. 
 1H NMR (CDCl3, 300 MHz) δ/ppm: 7.24 (dd, 2H, J = 
7.3 Hz, J = 1.5 Hz), 7.11 (td, 2H, J = 7.5 Hz, J = 1.6 Hz), 6.91 
(td, 2H, J = 6.8 Hz, J = 0.8 Hz), 6.76 (dd, 2H, J = 8.1 Hz, J = 0.6 
Hz), 6.09 (t, 2H, J = 6.7 Hz), 2.04 (s, 6H), 1.80-1.69 (m, 4H), 
1.42-1.18 (m, 4H), 1.01 (s, 18H), 0.25 (s, 12H); 13C NMR 
(CDCl3, 75 MHz) δ/ppm: 169.9, 152.3, 131.7, 128.1, 126.5, 
120.9, 118.3, 70.9, 35.5, 25.7, 25.5, 21.1, 18.1, −4.1; HRMS 
(MALDI TOF/TOF): calcd. for C34H54O6Si2 [M]+ 614.3459; 
found 614.3429. 
 
1,7-Bis[2-(tert-butyldimethylsilyloxy)phenyl]heptane-1,7-
diacetate (2b) 
According to the general procedure, from 4b (0.27 g, 0.50 
mmol), acetyl chloride (0.16 g, 2.25 mmol) and pyridine the 
reaction furnished the product (0.16 g, 50 %) in the form of 
colorless viscous oil. 
 1H NMR (CDCl3, 300 MHz) δ/ppm: 7.26 (dd, 2H, J = 
7.3 Hz, J = 1.4 Hz), 7.11 (td, 2H, J = 7.9 Hz, J = 1.4 Hz), 6.92 
(t, 2H, J = 7.3 Hz), 6.77 (d, 2H, J = 8.1 Hz), 6.09 (t, 2H, J = 
6.5 Hz), 2.05 (s, 6H), 1.80-1.68 (m, 4H), 1.37–1.16 (m, 6H), 
1.02 (s, 18H), 0.26 (s, 12H); 13C NMR (CDCl3, 75 MHz) δ / 
ppm: 170.0, 152.3, 131.8, 128.0, 126.5, 120.9, 118.3, 70.9, 
35.5, 29.4, 25.7, 25.4, 21.1, 18.1, −4.3; HRMS (MALDI 
TOF/TOF): calcd. for C35H56O6Si2 [M]+ 628.3615; found 
628.3606. 
 
1,8-Bis[2-(tert-butyldimethylsilyloxy)phenyl]octane-1,8-
diacetate (2c) 
According to the general procedure, from 4c (0.28 g, 0.50 
mmol) and acetyl chloride (0.16 g, 2.25 mmol) and pyridine 
the reaction furnished the product (0.21 g, 65 %) in the 
form of colorless viscous oil. 
 1H NMR (CDCl3, 300 MHz) δ / ppm: 7.26 (dd, 2H, J = 
7.3 Hz, J = 1.4 Hz), 7.11 (td, 2H, J = 7.9 Hz, J = 1.4 Hz), 6.92 
(t, 2H, J = 7.4 Hz), 6.77 (dd, 2H, J = 8.0 Hz, J = 0.5 Hz), 6.10 
(t, 2H, J = 6.4 Hz), 2.05 (s, 6H), 1.82–1.68 (m, 4H), 1.31–1.18 
(m, 8H), 1.02 (s, 18H), 0.26 (s, 12H); 13C NMR (CDCl3, 150 
MHz) δ/ppm: 170.1, 152.3, 131.8, 128.0, 126.5, 120.9, 
118.2, 70.9, 35.6, 29.4, 25.7, 25.4, 21.1, 18.1, −4.1; HRMS 
(MALDI TOF/TOF): calcd. for C36H58O6Si2 [M-H]- 641.3694, 
found 641.3690. 
 
One-pot synthesis of 2 - general procedure 
In a two neck flask (50 mL), equipped with a condenser and 
septum, under inert N2 atmosphere, Mg (1.3 mmol), dry 
ether (2mL) and a crystal of iodine were added. A small 
quantity of the solution of the 1,n-dibromoalkane (0.5 
mmol) in ether (5 mL) was added dropwise through the 
septum via a syringe. When the reaction was initiated by 
heating, the remaining dibromoalkane solution was added 
at rt. After the addition was complete, the reaction mixture 
was heated at the temperature of reflux for 1 h, cooled to 
rt, and a solution of the protected salicylaldehyde (3, 1 
mmol) in ether (3 mL) was added dropwise. The reaction 
mixture was stirred at rt for 2 h, and then acetyl chloride 
(2.2 mmol) was added and the stirring was continued over 
2 h. The solvent was removed on a rotary evaporator and 
the residue was purified on a column of silica gel using 
hexane/diethyl ether (9:1) as eluent to afford the pure 
product in the form of colorless viscous oil. 
 
1,8-Bis[2-(tert-butyldimethylsilyloxy)phenyl]octane-1,8-
diacetate (2c) 
According to the general procedure, the Grignard reagent 
was prepared from 1,6-dibromohexane (0.30 mL, 1.43 
mmol) and Mg (0.11 g, 4.48 mmol) in dry ether. In the 
reaction with the protected aldehyde (5, 0.65 g, 2.76 
mmol), and subsequently acetyl chloride (0.46 mL, 6.47 
mmol) the product (0.43 g, 48 %) was obtained in the form 
of colorless viscous oil. 
 
1,9-Bis[2-(tert-butyldimethylsilyloxy)phenyl]nonane-1,9-
diacetate (2d) 
According to the general procedure, the Grignard reagent 
was prepared from 1,7-dibromoheptane (0.08 mL, 0.47 
mmol) and Mg (0.04 g, 1.65 mmol) in dry ether. In the 
reaction with the protected aldehyde (5, 0.22 g, 0.93 
mmol), and subsequently acetyl chloride (0.13 mL, 1.83 
mmol) the product (60 mg, 22 %) was obtained in the form 
of colorless viscous oil. 
 1H NMR (CDCl3, 600 MHz) δ/ppm: 7.26 (dd, 2H, J = 
7.7 Hz, J = 1.5 Hz), 7.11 (td, 2H, J = 7.6 Hz, J = 1.6 Hz), 6.92 
(t, 2H, J = 7.6 Hz), 6.78 (d, 2H, J = 8.1 Hz), 6.11 (t, 2H, J = 6.2 
Hz), 2.06 (s, 6H), 1.81-1.69 (m, 4H), 1.37-1.28 (m, 2H), 1.26-
1.19 (m, 8H), 1.02 (s, 18H), 0.26 (s, 12H); 13C NMR (CDCl3, 
150 MHz) δ / ppm: 170.0, 152.3, 131.9, 128.0, 126.6, 120.9, 
118.3 71.0, 35.6, 29.4, 29.3, 25.7, 25.4, 21.1, 18.1, −4.1; 
HRMS (MALDI TOF/TOF): calcd. for C37H60O6Si2 [M]+ 
656.3928; found 656.3950. 
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1,10-Bis[2-(tert-butyldimethylsilyloxy)phenyl]decane-
1,10-diacetate (2e) 
According to the general procedure, the Grignard reagent 
was prepared from 1,8-dibromooctane (0.09 mL, 0.48 
mmol) and Mg (0.04 g, 1.72 mmol) in dry ether. In the 
reaction with the protected aldehyde (5, 0.22 g, 0.93 
mmol), and subsequently acetyl chloride (0.13 mL, 1.83 
mmol) the product (33 mg, 11 %) was obtained in the form 
of colorless viscous oil. 
 1H NMR (CDCl3, 600 MHz) δ/ppm: 7.27 (dd, 2H, J = 
7.7 Hz, J = 1.6 Hz), 7.11 (td, 2H, J = 7.6 Hz, J = 1.6 Hz), 6.92 
(td, 2H, J = 7.4 Hz, J = 0.6 Hz), 6.78 (dd, 2H, J = 8.1 Hz, J = 0.8 
Hz), 6.11 (t, 2H, J = 6.6 Hz), 2.06 (s, 6H), 1.82-1.69 (m, 4H), 
1.27–1.18 (m, 10H), 1.03 (s, 18H), 0.26 (s, 12H); 13C NMR 
(CDCl3, 150 MHz) δ/ppm: 170.0, 152.3, 131.9, 128.0, 126.6, 
120.9, 118.3, 71.0, 35.6, 29.3, 25.7, 25.4, 21.1, 18.2, −4.3; 
HRMS (MALDI TOF/TOF): calcd. for C38H62O6Si2 [M+Na-H]− 
692.3904; found 692.3893. 
 
2-(1-Azido-1-propyl)phenol (8) 
A flask (5 mL) was charged with 7 (30 mg, 0.09 mmol), sodium 
azide (19 mg, 0.29 mmol), acetonitrile (0.6 mL) and H2O (0.3 
mL). To the reaction mixture, a solution of KF (12 mg, 0.21 
mmol) in H2O (0.3 mL) was added dropwise. The reaction 
mixture was stirred at rt for 12 h, diluted with H2O (10 mL), 
and extracted with ethyl acetate (3 × 10 mL). The organic 
extracts were dried over anhydrous MgSO4, filtered, and the 
solvent was removed on a rotary evaporator. The residue 
was chromatographed on a column of silica gel by use of 
CH2Cl2/CH3OH (9:1) as eluent to afford the pure product (8 
mg, 47 %) in the form of colorless viscous oil. 
 1H NMR (CDCl3, 600 MHz) δ/ppm: 7.19 (td, 1H, J = 8.0 
Hz, J = 1.2 Hz), 7.18 (dd, 1H, J = 7.6 Hz, J = 1.3 Hz), 6.91 (td, 1H, 
J = 7.4 Hz, J = 0.9 Hz), 6.85 (dd, 1H, J = 8.0 Hz, J = 0.9 Hz), 4.62 
(t, 1H, J = 6.9 Hz), 1.94–1.81 (m, 2H), 0.97 (t, 3H, J = 7.3 Hz). 
 
Methanolysis of 2c 
Bisphenol 2c (30 mg, 0.05 mmol) was dissolved in methanol 
(2.0 mL), and a solution of KF (19 mg, 0.33 mmol) in H2O 
(0.3 mL) was added dropwise. The mixture was stirred at rt 
for 1 h, transferred to a separatory funnel, diluted with H2O 
(10 mL) and extracted with diethyl ether (3 × 5 mL). The 
combined organic extracts were dried over anhydrous 
MgSO4, filtered and the solvent was removed on a rotary 
evaporator. The residue was purified on a column of silica 
gel using cyclohexane/EtOAc (7:1) as eluent to afford 
bisphenol 9 (8 mg, 49 %) and 10 (6 mg, 33 %) in the form of 
colorless viscous oils. 
 
2,2'-(1,8-Dimethoxyoctane-1,8-diyl)diphenol (9): 1H NMR 
(CDCl3, 600 MHz) δ/ppm: 7.91 (s, 2H), 7.20-7.16 (m, 2H), 
6.93-6.90 (m, 2H), 6.87-6.85 (m, 2H), 6.84-6.81 (m, 2H), 
4.22 (t, 2H, J = 6.9 Hz), 3.37 (s, 6H), 1.92-1.84 (m, 2H), 1.72-
1.63 (m, 2H), 1.43-1.35 (m, 2H), 1.31-1.19 (m, 6H); 13C NMR 
(CDCl3, 150 MHz) δ/ppm: 155.3 (s, 2C), 128.9 (d, 2C), 128.4 
(d, 2C), 125.0 (s, 2C), 119.5 (d, 2C), 116.7 (d, 2C), 86.0 (d, 
2C), 57.2 (q, 2C), 35.8 (t, 2C), 29.2 (t, 2C), 25.6 (t, 2C); HRMS 
(MALDI TOF/TOF): calcd. for C22H30O4 [M+H]+ 359.2222; 
found 359.2235. 
 
1,8-Bis(2-hydroxyphenyl)-8-methoxyoctyl acetate (10): 1H 
NMR (CDCl3, 600 MHz) δ/ppm: 7.91 (d, 1H, J = 1.4 Hz), 7.30 (br. 
s, 1H), 7.27–7.25 (m, 1H), 7.23-7.19 (m, 1H), 7.19-7.15 (m, 1H), 
6.94–6.90 (m, 3H), 6.86 (dd, 1H, J = 8.1 Hz, J = 1.0 Hz), 6.82 (tt, 
1H, J = 6.3 Hz, J = 1.0 Hz), 5.80 (t, 1H, J = 7.0 Hz), 4.22 (dd (t), 
1H, J = 6.9 Hz), 3.37 (d, 3H, J = 0.8 Hz), 2.07 (d, 3H, J = 1.2 Hz), 
2.07-2.01 (m, 1H), 1.91-1.81 (m, 2H), 1.72-1.65 (m, 1H), 1.34–
1.16 (m, 8H); 13C NMR (CDCl3, 150 MHz) δ/ppm: 172.6 (s), 
155.3 (s), 154.6 (s), 129.9 (d), 128.9 (d), 128.4 (d), 127.4 (d), 
125.6 (s), 125.0 (s), 120.8 (d), 119.6 (d), 118.0 (d), 116.7 (d), 
86.0 (d), 72.1 (d), 57.2 (q), 35.8 (t), 33.5 (t), 29.1 (t), 29.0 (t), 
25.8 (t), 25.6 (t), 21.1 (q); HRMS (MALDI TOF/TOF): calcd. for 
C23H30O5 [M+H]+ 387.2171; found 387.2160. 
 
Alkaline Agarose Gel Assay 
Plasmid CMVbeta DNA (2 μg) was mixed with bisphenols 
2a–2e (1 mM) and KF (200 mM) in PBS buffer (pH = 7.4). 
After 18 h incubation, the samples were added to the 
alkaline agarose gel loading buffer [50 mM NaOH, 1 mM 
ethylenediaminetetraacetic acid (EDTA), 3 % Ficoll, and 
0.02 % bromophenol blue] and loaded on a 1 % agarose gel. 
Prior to the loading, the gel was soaked in 50 mM NaOH 
and 1 mM EDTA for 1h, and the same solution was used as 
the running buffer. Gels were run at 30 V constant voltage 
in horizontal electrophoresis system (BIO-RAD, USA) for 5 
h. After the run, gels were neutralized with 0.5 M Tris (pH 
7) for 30 min, and stained with ethidium bromide (1 μg/mL) 
for 30 min. Resulting products were visualized and 
documented with UV light at 254 nm (Image Master VDS, 
Pharmacia Biotech, Sweden). As a positive control, instead 
of 2 and KF, the plasmid was treated with psoralene (20 
µM) and irradiated in a Luzchem reactor 5 min with 6 lamps 
(1 lamp 8 W) at 300 nm. 
 
DNA Denaturation Experiments 
For the DNA denaturation experiments, a stock solution of 
compound 2 was prepared in DMSO (c = 2×10−2 M), 
whereas a stock solution of ct-DNA (c = 1.1×10−3 M) and a 
stock solution of KF (c = 0.2 M) were prepared in H2O-DMSO 
(8:2), containing sodium cacodylate (c = 0.05 M, pH = 7.0). 
The cross-linking was attempted by a treatment of DNA 
solution (20 µL) with compound 2 (10 µL) and KF (20 µL) 
which were incubated 3 h. This solution (40 µL) was then 
diluted [(ct-DNA (c = 1.76 × 10−5 M), in the presence of 2  
(c = 1.6 × 10−4 M), and KF (0.2 M)] and the dependence of the 
absorbance at 260 nm as a function of temperature was 
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measured. The melting temperature Tm values are the mid-
points of the transition curves, determined from the maximum 
of the first derivative. ∆Tm values were calculated by sub-
tracting Tm of the free nucleic acid from that of the respective 
complex with ∆Tm values are the average of at least two indep-
endent measurements and the error in ∆Tm is ca. ± 0.5 °C. 
 
Antiproliferative Investigation 
MTT test was conducted on 2 human tumour cell lines, 
MCF7 (breast adenocarcinoma) and SUM159 (pleomorphic 
breast carcinoma). MCF7 cells were cultured as monolayers 
and maintained in DMEM medium, supplemented with 10 
% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL 
penicillin and 100 μg/mL streptomycin in a humidified 
atmosphere with 5 % CO2 at 37 °C. The cell line SUM159 
was maintained using the same conditions, but in different 
cell media: Ham’s F12 medium supplemented with 5 % fetal 
bovine serum, 2 mM L-glutamine, 100 U/mL penicillin and 
100 μg/mL streptomycin, 5 μg/mL insulin, 1 μg/mL hydro-
cortisone. Cell lines were inoculated in parallel onto a series 
of standard 96-well microtiter plates on day 0. The cells 
were seeded at 2 × 104 cells/mL for SUM159 and 3 × 104 
cells/mL for MCF7, depending on the doubling times of 
specific cell line. Test agents were then added in five 10-
fold dilutions (10−8 to 10−4 M) and incubated for a further 
72 h. For each cell line one of the plates was treated with 
1mM KF, concentration that has low impact on cells (see 
supporting information) while the other was treated with 
the cell culture medium, 2 h after the addition of the 
compounds. Suitable concentration of KF was determined 
in advance by titration of KF using the same cell lines (see 
the Supporting material, Figure S3). Working dilutions of 
compounds were freshly prepared on the day of testing. 
After 72 h of incubation, the cell growth rate was evaluated 
by performing the MTT assay, as described previously.[22,23] 
The results were expressed as IC50, a concentration neces-
sary for 50 % of inhibition. The IC50 values for each 
compound were calculated from concentration-response 
curves using linear regression analysis. Each result is an 
average value from at least two separate experiments. 
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